Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
Cationic amphiphile/DNA complexes
 Novel cationic amphiphiles are provided that facilitate transport of biologically active (therapeutic) molecules into cells. The amphiphiles contain lipophilic groups derived from steroids, from mono or dialkylamines, or from alkyl or acyl groups; and cationic groups, protonatable at physiological pH, derived from amines, alkylamines or polyalkylamines. There are provided also therapeutic compositions prepared typically by contacting a dispersion of one or more cationic amphiphiles with the therapeutic molecules. Therapeutic molecules that can be delivered into cells according to the practice of the invention include DNA, RNA, and polypeptides. Representative uses of the therapeutic compositions of the invention include providing gene therapy, and delivery of antisense polynucleotides or biologically active polypeptides to cells. With respect to therapeutic compositions for gene therapy, the DNA is provided typically in the form of a plasmid for complexing with the cationic amphiphile. Novel and highly effective plasmid constructs are also disclosed, including those that are particularly effective at providing gene therapy for clinical conditions complicated by inflammation. Additionally, targeting of organs for gene therapy by intravenous administration of therapeutic compositions is described. 
Genzyme Corporation
A A A C A A C C C A A C A A A A A
A61P A61K A61K C07J A61P A61K C07J C07J C12N A61K A61P C07J A61K A61P A61K A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Seng H. Rebecca G. Ronald K. S. Catherine Simon J. Chau-Dung Craig S. Edward R. Nelson S. David J. John
Cheng Bagley Scheule Hubbard Eastman Chang Siegel Lee Yew Harris Marshall